Gardner Russo & Quinn’s Celgene Corp CELG Stock Holding History

Gardner Russo & Quinn’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-500	Closed	-$52K	–	179
2017 Q4	$52K	Buy	+500	New	+$56.4K	﹤0.01%	156

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Gardner Russo & Quinn's CELG Position: Q1 2018 in Review

Gardner Russo & Quinn sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 500 shares — an estimated $52K sold.

Gardner Russo & Quinn first reported a position in CELG in Q4 2017 and held it in 1 quarter. The position peaked at $52K in Q4 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

Gardner Russo & Quinn reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
Gardner Russo & Quinn sold 500 Celgene Corp shares in Q1 2018, an estimated $52K.
Gardner Russo & Quinn first reported a position in Celgene Corp in Q4 2017 and held it in 1 quarter.
Gardner Russo & Quinn's Celgene Corp position peaked at $52K in Q4 2017.
1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Gardner Russo & Quinn's 13F filing for Q1 2018, filed 11 May 2018.